121 related articles for article (PubMed ID: 3886792)
1. An examination of the TRF assay reveals a heterogeneity of TRF-like activities.
Eisenberg L
J Immunol; 1985 Jun; 134(6):3920-5. PubMed ID: 3886792
[TBL] [Abstract][Full Text] [Related]
2. TRF requirements for in vitro PFC responses to SRBC and R36a. I. TRF is distinct from IL 2 but indistinguishable from polyclonal BCSF.
Eisenberg L; Prystowsky MB; Dick RF; Sosman JA; Fitch FW; Quintáns J
J Immunol; 1984 Mar; 132(3):1305-10. PubMed ID: 6363538
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation in the rat: cellular and molecular requirements for B cell responses to types 1, 2, and T-dependent antigens.
Eldridge JH; Kimura S; Morisaki I; Michalek SM; Hamaoka T; Hamada S; McGhee JR
J Immunol; 1985 Apr; 134(4):2236-46. PubMed ID: 2857748
[TBL] [Abstract][Full Text] [Related]
4. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.
Koyama N; Harada N; Takahashi T; Mita S; Okamura H; Tominaga A; Takatsu K
Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472
[TBL] [Abstract][Full Text] [Related]
5. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
[TBL] [Abstract][Full Text] [Related]
6. Evidence for existence of two distinct TNP-Ficoll-responsive B cell subpopulations preferentially reactive either to a T cell-replacing factor (B151-TRF) or to a signal from accessory cells.
Hayashi S; Ono S; Miyake K; Tsukada S; Takatsu K; Hamaoka T
J Immunol; 1986 Mar; 136(6):2069-75. PubMed ID: 3485139
[TBL] [Abstract][Full Text] [Related]
7. In vitro analysis of allogeneic lymphocyte interaction. VIII. Characterization of helper components of allogeneic effect factor (AEF) that activate Lyb5+ and Lyb5- B cells to respond to thymus-dependent and thymus-independent antigens.
Delovitch TL; Kaufman K; Gorczynski RD; Sinclair GD
J Immunol; 1983 Nov; 131(5):2246-53. PubMed ID: 6605380
[TBL] [Abstract][Full Text] [Related]
8. Establishment of three PPD-reactive helper T cell clones with distinct functions in B cell activation.
Sano Y; Yamada G; Dobashi K; Mizuochi T; Hamaoka T; Takatsu K
J Immunol; 1984 Aug; 133(2):629-35. PubMed ID: 6234353
[TBL] [Abstract][Full Text] [Related]
9. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and -stimulating activity.
Takahama Y; Ono S; Hara Y; Hayashi S; Dobashi K; Hamaoka T
J Immunol; 1985 Oct; 135(4):2534-40. PubMed ID: 3897376
[TBL] [Abstract][Full Text] [Related]
10. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. II. Activation of B cells by cross-linkage or aggregation of the TRF acceptor molecule.
Tominaga A; Takatsu K; Hamaoka T
J Immunol; 1982 Jun; 128(6):2581-5. PubMed ID: 6978908
[TBL] [Abstract][Full Text] [Related]
11. Disparate functional properties of two interleukin 1-responsive Ly-1+2- T cell clones: distinction of T cell growth factor and T cell-replacing factor activities.
Rao A; Mizel SB; Cantor H
J Immunol; 1983 Apr; 130(4):1743-8. PubMed ID: 6220067
[TBL] [Abstract][Full Text] [Related]
12. Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.
Garchon HJ; Levi-Strauss M; Carnaud C; Bach JF
J Immunol; 1983 Feb; 130(2):777-80. PubMed ID: 6600254
[TBL] [Abstract][Full Text] [Related]
13. Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.
Couderc J; Février M; Duquenne C; Sourbier P; Liacopoulos P
Immunology; 1987 May; 61(1):71-6. PubMed ID: 3294578
[TBL] [Abstract][Full Text] [Related]
14. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
15. Synergy between T cell-replacing factor and bacterial lipopolysaccharides (LPS) in the primary antibody response in vitro: a model for lipopolysaccharide adjuvant action.
Jacobs DM
J Immunol; 1979 Apr; 122(4):1421-6. PubMed ID: 376717
[TBL] [Abstract][Full Text] [Related]
16. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
17. Purification and physicochemical characterization of murine T cell replacing factor (TRF).
Takatsu K; Harada N; Hara Y; Takahama Y; Yamada G; Dobashi K; Hamaoka T
J Immunol; 1985 Jan; 134(1):382-9. PubMed ID: 3871109
[TBL] [Abstract][Full Text] [Related]
18. Antigen-nonspecific T cell-derived factors in B cell activation: differences in the requirements for interleukin 2 in responses of unprimed and primed B cells.
Kuhara T; Haughton G; Corley RB
Eur J Immunol; 1985 Aug; 15(8):787-93. PubMed ID: 3875491
[TBL] [Abstract][Full Text] [Related]
19. Molecular properties and regulation of mRNA expression for murine T cell-replacing factor/IL-5.
Tominaga A; Matsumoto M; Harada N; Takahashi T; Kikuchi Y; Takatsu K
J Immunol; 1988 Feb; 140(4):1175-81. PubMed ID: 2893824
[TBL] [Abstract][Full Text] [Related]
20. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. I. TRF-substituting activity of anti-TRF acceptor site(s) antibody in the triggering of B cells.
Takatsu K; Sano Y; Hashimoto N; Tomita S; Hamaoka T
J Immunol; 1982 Jun; 128(6):2575-80. PubMed ID: 6978907
[No Abstract] [Full Text] [Related]
[Next] [New Search]
